These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29452047)

  • 1. Lessons learned from Ebola Vaccine R&D during a public health emergency.
    Kieny MP
    Hum Vaccin Immunother; 2018; 14(9):2114-2115. PubMed ID: 29452047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola: Lessons on Vaccine Development.
    Feldmann H; Feldmann F; Marzi A
    Annu Rev Microbiol; 2018 Sep; 72():423-446. PubMed ID: 30200851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.
    Henao-Restrepo AM; Preziosi MP; Wood D; Moorthy V; Kieny MP;
    Curr Opin Virol; 2016 Apr; 17():138-144. PubMed ID: 27180074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
    Tully CM; Lambe T; Gilbert SC; Hill AV
    Lancet Infect Dis; 2015 Mar; 15(3):356-9. PubMed ID: 25595637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program.
    Gupta SB; Coller BA; Feinberg M
    Expert Rev Vaccines; 2018 Oct; 17(10):913-923. PubMed ID: 30269612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus vaccines - reality or fiction?
    Mire CE; Geisbert TW; Feldmann H; Marzi A
    Expert Rev Vaccines; 2016 Nov; 15(11):1421-1430. PubMed ID: 27078187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola vaccines - Where are we?
    Watle SV; Norheim G; Røttingen JA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2700-2703. PubMed ID: 27548643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
    Fathi A; Dahlke C; Addo MM
    Hum Vaccin Immunother; 2019; 15(10):2269-2285. PubMed ID: 31368826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
    Coller BG; Blue J; Das R; Dubey S; Finelli L; Gupta S; Helmond F; Grant-Klein RJ; Liu K; Simon J; Troth S; VanRheenen S; Waterbury J; Wivel A; Wolf J; Heppner DG; Kemp T; Nichols R; Monath TP
    Vaccine; 2017 Aug; 35(35 Pt A):4465-4469. PubMed ID: 28647166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.
    Bell BP; Damon IK; Jernigan DB; Kenyon TA; Nichol ST; O'Connor JP; Tappero JW
    MMWR Suppl; 2016 Jul; 65(3):4-11. PubMed ID: 27389903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebola virus vaccine: benefit and risks of adenovirus-based vectors.
    Mennechet FJ; Tran TT; Eichholz K; van de Perre P; Kremer EJ
    Expert Rev Vaccines; 2015; 14(11):1471-8. PubMed ID: 26325242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an Ebola Vaccine Study - Sierra Leone.
    Widdowson MA; Schrag SJ; Carter RJ; Carr W; Legardy-Williams J; Gibson L; Lisk DR; Jalloh MI; Bash-Taqi DA; Kargbo SA; Idriss A; Deen GF; Russell JB; McDonald W; Albert AP; Basket M; Callis A; Carter VM; Ogunsanya KR; Gee J; Pinner R; Mahon BE; Goldstein ST; Seward JF; Samai M; Schuchat A
    MMWR Suppl; 2016 Jul; 65(3):98-106. PubMed ID: 27387395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arranging good clinical practices training and trial monitoring for a vaccine efficacy study during a public health emergency of international concern.
    Tapia MD; Doumbia M; Dembele R; Ball K; N'Diaye B; Amadou H; Charara S; Henao-Restrepo AM; Merle CS; Sow SO; Levine MM
    Vaccine; 2020 May; 38(24):4050-4056. PubMed ID: 32284269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency.
    Larson GS; Baseler BR; Hoover ML; Pierson JF; Tegli JK; Johnson MP; Kieh MWS; McNay LA; Njoh WS
    Am J Trop Med Hyg; 2017 Jul; 97(1):10-15. PubMed ID: 28719299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
    Kennedy SB; Neaton JD; Lane HC; Kieh MW; Massaquoi MB; Touchette NA; Nason MC; Follmann DA; Boley FK; Johnson MP; Larson G; Kateh FN; Nyenswah TG
    Clin Trials; 2016 Feb; 13(1):49-56. PubMed ID: 26768572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.
    Mooney T; Smout E; Leigh B; Greenwood B; Enria L; Ishola D; Manno D; Samai M; Douoguih M; Watson-Jones D
    Clin Trials; 2018 Oct; 15(5):436-443. PubMed ID: 29895178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ebola Epidemic. High hopes for Guinean vaccine trial.
    Enserink M
    Science; 2015 Jan; 347(6219):219-20. PubMed ID: 25593164
    [No Abstract]   [Full Text] [Related]  

  • 18. Closer than ever to an Ebola virus vaccine.
    Banadyga L; Marzi A
    Expert Rev Vaccines; 2017 May; 16(5):401-402. PubMed ID: 28322076
    [No Abstract]   [Full Text] [Related]  

  • 19. Ebola vaccines in clinical trial: The promising candidates.
    Wang Y; Li J; Hu Y; Liang Q; Wei M; Zhu F
    Hum Vaccin Immunother; 2017 Jan; 13(1):153-168. PubMed ID: 27764560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World after Ebola: An Overview of Ebola Complications, Vaccine Development, Lessons Learned, Financial Losses, and Disease Preparedness.
    Waheed Y; Malik S; Khan M; Najmi MH
    Crit Rev Eukaryot Gene Expr; 2019; 29(1):77-84. PubMed ID: 31002597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.